Metropolitan Life Insurance Company (MetLife)’s Zymergen Inc. Common Stock ZY Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,198	Closed	-$17.9K	–	2465
2022 Q1	$17.9K	Sell	6,198 -17,421	-74%	-$74K	﹤0.01%	2142
2021 Q4	$158K	Buy	23,619 +17,775	+304%	+$173K	﹤0.01%	2187
2021 Q3	$77K	Sell	5,844 -5,844	-50%	-$124K	﹤0.01%	2658
2021 Q2	$468K	Buy	+11,688	New	+$461K	﹤0.01%	2027

Other funds holding ZY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

TVPI

True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DCI

Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TSV

Two Sigma Ventures New York $9.61M AUM 58.41% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ZY Position: Q2 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Zymergen Inc. Common Stock (ZY) in Q2 2022, closing a stake of 6,198 shares — an estimated $17.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ZY in Q2 2021 and held it in 4 quarters. The position peaked at $468K in Q2 2021. 81 funds tracked by Wall St. Rank hold ZY as of Q2 2022.

Metropolitan Life Insurance Company (MetLife) reported no remaining Zymergen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 6,198 Zymergen Inc. Common Stock shares in Q2 2022, an estimated $17.9K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Metropolitan Life Insurance Company (MetLife)'s Zymergen Inc. Common Stock position peaked at $468K in Q2 2021.
81 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q2 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.